Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

Clinical trial NCT01020396 · COMPLETED

Trial details

NCT number: NCT01020396
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bacterial Vaginosis

Start date: 2002-01-01
Primary completion: 2003-03-01
Enrollment: 579

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.